Allspring Global Investments
KYMR icon

Allspring Global Investments’s Kymera Therapeutics KYMR Stock Holding History

Allspring Global Investments’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-5,183
Closed -$72K – 2498
2023
Q3 		$72K Buy
5,183
+1,310
+34% +$26.3K ﹤0.01% 2128
2023
Q2 		$89K Buy
3,873
+53
+1% +$1.52K ﹤0.01% 2099
2023
Q1 		$113K Sell
3,820
-1,075
-22% -$34.7K ﹤0.01% 2008
2022
Q4 		$122K Sell
4,895
-54
-1% -$1.44K ﹤0.01% 1997
2022
Q3 		$107K Sell
4,949
-1,113
-18% -$29.3K ﹤0.01% 2059
2022
Q2 		$119K Sell
6,062
-15,134
-71% -$353K ﹤0.01% 1996
2022
Q1 		$897K Buy
21,196
+865
+4% +$36.5K ﹤0.01% 1950
2021
Q4 		$1.29M Buy
+20,331
New +$1.18M ﹤0.01% 1782

Other funds holding KYMR

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Avoro Capital Advisors
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments's KYMR Position: Q4 2023 in Review

Allspring Global Investments sold out of Kymera Therapeutics (KYMR) in Q4 2023, closing a stake of 5,183 shares — an estimated $72K sold.

Allspring Global Investments first reported a position in KYMR in Q4 2021 and held it in 8 quarters. The position peaked at $1.29M in Q4 2021. 136 funds tracked by Wall St. Rank hold KYMR as of Q4 2023.

  • Allspring Global Investments reported no remaining Kymera Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 5,183 Kymera Therapeutics shares in Q4 2023, an estimated $72K.
  • Allspring Global Investments first reported a position in Kymera Therapeutics in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Kymera Therapeutics position peaked at $1.29M in Q4 2021.
  • 136 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.